河北医科大学学报 ›› 2021, Vol. 42 ›› Issue (5): 551-554,596.doi: 10.3969/j.issn.1007-3205.2021.05.012

• • 上一篇    下一篇

血管腔内治疗致造影剂肾病的相关危险因素分析

  

  1. 广西医科大学第四附属医院柳州市工人医院血管外科,广西 柳州 545005
  • 出版日期:2021-05-25 发布日期:2021-05-28
  • 作者简介:罗长志(1984-),男,广西柳州人,广西医科大学第四附属医院柳州市工人医院主治医师,医学硕士,从事血管外科疾病诊治研究。
  • 基金资助:
    柳州市科技局重点研发计划(2018BJ10508);广西高校中青年教师基础能力提升项目(2018KY0126)

Analysis of risk factors related to contrast-induced nephropathy in endovascular treatment

  1. Department of Vascular Surgery, Worker′s Hospital of Liuzhou City, the Fourth Affiliated Hospital of
    Guangxi Medical University, Liuzhou 545005, China
  • Online:2021-05-25 Published:2021-05-28

摘要: 目的  探讨血管外科腔内治疗致造影剂肾病的相关危险因素。
方法  回顾性分析行腔内治疗患者279例的临床资料。根据腔内治疗前后肾功能的变化分为造影剂肾病组、非造影剂肾病组。比较2组性别、年龄、体重、合并症(高血压、糖尿病、冠心病)、主要诊断、造影剂类型、剂量、术前肾功能及个人造影剂限量超量使用情况,分析腔内治疗致造影剂肾病的相关危险因素。
结果  279例腔内治疗患者发生造影剂肾病37例(13.3%),3例需临时血液透析治疗。单因素分析结果显示,2组性别、主要诊断、造影剂类型、剂量、术前肾功能及个人造影剂限量超量使用差异有统计学意义(P<0.05);多因素回归分析结果显示,个人造影剂限量超量使用是腔内治疗术后造影剂肾病的危险因素(P<0.05)。
结论  个人造影剂限量超量使用是腔内治疗发生造影剂肾病的独立危险因素,发病风险是未超量使用者的3.8倍;术前应个体化计算造影剂限量,避免超量使用,对超量患者应采取更积极的预防措施。

关键词: 血管外科, 腔内治疗, 造影剂肾病, 危险因素

Abstract: Objective  To investigate the risk factors related to contrast -induced nephropathy(CIN) in endovascular surgery.
Methods  The clinical data of 279 patients who underwent endovascular surgery were retrospectively analyzed. According to the changes of renal function before and after endovascular treatment, they were divided into CIN group and non-CIN group. The gender, age, weight, comorbidities(hypertension, diabetes, coronary heart disease), major diagnosis, type and dose of contrast, preoperative renal function, and excessive use of contrast compared, and the risk factors for CIN in endovascular treatment were analyzed.
Results  There were 37 cases(13.3%) of CIN in 279 patients during endovascular treatment, and 3 cases required temporary hemodialysis treatment. The univariate analysis showed significant difference between two groups with respect to gender, major diagnosis, type and dose of contrast, preoperative renal function, and excessive use of contrast(P<0.05). Multivariate regression analysis showed that the excessive use of contrast was a risk factor for CIN after endovascular treatment(P<0.05).
Conclusion  Excessive use of contrast is an independent risk factor for CIN in endovascular treatment, and the risk of disease onset is 3.8 times that of non-overdose users. The maximal acceptable contrast dose should be calculated individually before surgery to avoid over-use, and preventive measures should be taken more actively for patients with overdose.

Key words: vascular surgery, endovascular treatment, contrast-induced nephropathy, risk factor